Drug Type Synthetic peptide |
Synonyms- |
Target- |
Action inhibitors |
Mechanism Protein synthesis inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acinetobacter Baumannii Infection | Preclinical | United Kingdom | 29 Jul 2020 | |
Escherichia Coli Infections | Preclinical | United Kingdom | 29 Jul 2020 | |
Klebsiella pneumoniae infection | Preclinical | United Kingdom | 29 Jul 2020 | |
Pseudomonas aeruginosa infection | Preclinical | United Kingdom | 29 Jul 2020 | |
Staphylococcus Aureus Infections | Preclinical | United Kingdom | 29 Jul 2020 |